International legal practice Osborne Clarke has advised Creo Medical Group, a medical device company focused on the emerging field of surgical endoscopy, quoted on the AIM market of the London Stock Exchange, on a successful fundraising to raise £36.32m by way of a placing and an open offer.
Creo intends to use the net proceeds from the fundraising to, amongst other things, accelerate the commercial roll-out of its products in the United States, Europe, Middle East, and Africa and Asia Pacific regions, explore potential strategic acquisition opportunities and continue to develop its pipeline of commercial licensing and partnering opportunities.
The Osborne Clarke team that advised on the transaction was led by Corporate Partner Mark Wesker who was assisted by Associate Rebecca Ewing, Associate Liam O’Connor and Trainee Solicitor Bethany Filby. Mark also led the Osborne Clarke team which advised Creo on its £48.5m fundraising in 2018 and £52m fundraising in 2019.
Osborne Clarke’s Corporate team is considered the go-to practice for many businesses in the life sciences and healthcare sector. The team advises at every stage of company development across all corporate areas, from equity and debt fundraising to M&A, IPOs and JVs.